Marion de Jong obtained her MS degree in biochemistry and biology (CUM LAUDE) at Wageningen University and her PhD degree at the Erasmus University Rotterdam (Dept. Internal Medicine). She joined the Department of Nuclear Medicine, and in 2006 she was appointed Professor of Nuclear Biology. In 2010, the Depts. of Radiology and Nuclear Medicine joined forces at the pre-clinical level into the SPECTRIM group, headed by Marion. She is coauthor of >400 peer-reviewed papers (H-Index: 67), holds a number of patents, is PI in national and international research projects, and has served in multiple international committees and boards.
Scientific interests include preclinical and translational molecular multimodality imaging and radionuclide therapy.